<div id="readability-page-1"><p>Seilern Investment Management Ltd grew its stake in shares of  Zoetis Inc. (NYSE:ZTS - Free Report) by 15.4% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 72,310 shares of the company's stock after buying an additional 9,673 shares during the period. Zoetis makes up   0.8% of Seilern Investment Management Ltd's investment portfolio, making the stock its 16th biggest holding. Seilern Investment Management Ltd's holdings in Zoetis were worth $10,580,000 as of its most recent filing with the SEC.</p><ul><li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li></ul><p>A number of other institutional investors have also added to or reduced their stakes in ZTS. Nova Wealth Management Inc. bought a new stake in shares of  Zoetis in the 1st quarter worth approximately $25,000.  1248 Management LLC bought a new stake in  Zoetis in the first quarter valued at $27,000.  Saudi Central Bank acquired a new stake in shares of  Zoetis during the 1st quarter worth about $29,000.  REAP Financial Group LLC increased its holdings in shares of  Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company's stock worth $31,000 after buying an additional 131 shares in the last quarter.  Finally, NewSquare Capital LLC increased its holdings in  Zoetis by 69.1% during the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company's stock valued at $32,000 after purchasing an additional 85 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds. </p><h2>Analyst Ratings Changes</h2><p>Several analysts have weighed in on ZTS shares. HSBC  set a $140.00 price objective on Zoetis in a report on Wednesday, December 10th. Stifel Nicolaus cut their target price on Zoetis from $140.00 to $130.00 and set a &#34;hold&#34; rating on the stock in a research note on Tuesday, November 18th. The Goldman Sachs Group upgraded Zoetis to a &#34;buy&#34; rating in a research report on Monday, December 15th. KeyCorp assumed coverage on shares of Zoetis in a research report on Thursday, November 20th. They issued a &#34;sector weight&#34; rating on the stock. Finally, BTIG Research  reissued a &#34;buy&#34; rating and set a $160.00 price objective on shares of Zoetis in a research note on Wednesday, December 3rd. Six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of &#34;Hold&#34; and a consensus target price of $160.18.</p><ul><li>MarketBeat Week in Review – 07/31 - 08/04</li></ul><p><b>Check Out Our Latest Stock Report on ZTS</b></p><h2>Zoetis Trading Down 0.3%</h2><p>NYSE:ZTS opened at $122.34 on Monday. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The business's 50-day simple moving average is $128.86 and its 200-day simple moving average is $144.31. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.40. The stock has a market capitalization of $53.91 billion, a PE ratio of 20.60, a price-to-earnings-growth ratio of 2.66 and a beta of 0.97. </p><ul><li>Rising Dividend Make Zoetis a Doggone Winner</li></ul><p>Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same period last year, the company posted $1.58 EPS. The business's quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS.  Sell-side analysts expect that  Zoetis Inc. will post 6.07 earnings per share for the current fiscal year. </p><h2>Zoetis Increases Dividend</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis's previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. Zoetis's dividend payout ratio (DPR) is 35.69%. </p><h2>Zoetis Company Profile</h2> (Free Report)<p>Zoetis Inc <span>NYSE: ZTS<span></span></span> is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.  </p><p>Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Zoetis</li><li>I Shouldn't Be Sending You This</li><li>Wall Street Stock picker Names #1 Stock of 2026</li><li>End of America update</li><li>They Laughed at $30. They Won’t Laugh at $70.</li><li>How Long Will $1M Last in Retirement?</li></ul><p><strong>Want to see what other hedge funds are holding ZTS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Zoetis Right Now?</h2><p>Before you consider Zoetis, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p><p>While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Seilern Investment Management Ltd increased its stake in Zoetis Inc. by 15.4% in the third quarter, now holding 72,310 shares valued at $10,580,000. Zoetis represents 0.8% of Seilern's portfolio. The stock has a consensus "Hold" rating with a target price of $160.18. Zoetis reported a quarterly EPS of $1.70, surpassing estimates, and announced a dividend increase to $0.53 per share.</p>

Seilern Investment Management Ltd Buys 9,673 Shares of Zoetis Inc. $ZTS